Literature DB >> 33359909

Divergent erythroid megakaryocyte fates in Blvrb-deficient mice establish non-overlapping cytoprotective functions during stress hematopoiesis.

Natasha M Nesbitt1, Lisa E Malone1, Zhaoyan Liu2, Alexander Jares3, Dmitri V Gnatenko1, Yupo Ma3, Wei Zhu2, Wadie F Bahou4.   

Abstract

Cytoprotective mechanisms of heme oxygenases function by derivatizing heme to generate carbon monoxide, ferrous iron, and isomeric biliverdins, followed by rapid NAD(P)H-dependent biliverdin reduction to the antioxidant bilirubin using two non-overlapping biliverdin reductases that display biliverdin isomer-restricted redox activity. Although cytoprotective functions of heme oxygenases are widely recognized, concomitant effects of downstream biliverdin reductases remain incomplete. A computational model predicated on murine hematopoietic single-cell transcriptomic data identified Blvrb as a biological driver linked to the tumor necrosis factor stress pathway as a predominant source of variation defining hematopoietic cell heterogeneity. In vivo studies using Blvrb-deficient mice established the dispensable role of Blvrb in steady-state hematopoiesis, although model validation using aged Blvrb-deficient mice established an important cytoprotective function in stress hematopoiesis with dichotomous megakaryocyte-biased hematopoietic recovery. Defective stress erythropoiesis was evident in Blvrb-/- spleens and in bone marrow erythroid development, occurring in conjunction with defective lipid peroxidation as a marker of oxidant mishandling. Cell autonomous effects on megakaryocyte lineage bias were documented using multipotential progenitor assays. These data provide the first physiological function of murine Blvrb in a non-redundant pathway of stress cytoprotection. Divergent effects on erythroid/megakaryocyte lineage speciation impute a novel redox-regulated mechanism for lineage partitioning.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliverdin reductase; Cytoprotection; Erythropoiesis; Hematopoiesis; Heme oxygenase; Megakaryocytopoiesis; Redox; Stress

Mesh:

Substances:

Year:  2020        PMID: 33359909      PMCID: PMC8311568          DOI: 10.1016/j.freeradbiomed.2020.12.015

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  73 in total

Review 1.  Bacterial heme oxygenases.

Authors:  Nicole Frankenberg-Dinkel
Journal:  Antioxid Redox Signal       Date:  2004-10       Impact factor: 8.401

2.  A conditional knockout resource for the genome-wide study of mouse gene function.

Authors:  William C Skarnes; Barry Rosen; Anthony P West; Manousos Koutsourakis; Wendy Bushell; Vivek Iyer; Alejandro O Mujica; Mark Thomas; Jennifer Harrow; Tony Cox; David Jackson; Jessica Severin; Patrick Biggs; Jun Fu; Michael Nefedov; Pieter J de Jong; A Francis Stewart; Allan Bradley
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1.

Authors:  Y Liu; P R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B).

Authors:  O Cunningham; M G Gore; T J Mantle
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

5.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

6.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.

Authors:  Christian Frezza; Liang Zheng; Ori Folger; Kartik N Rajagopalan; Elaine D MacKenzie; Livnat Jerby; Massimo Micaroni; Barbara Chaneton; Julie Adam; Ann Hedley; Gabriela Kalna; Ian P M Tomlinson; Patrick J Pollard; Dave G Watson; Ralph J Deberardinis; Tomer Shlomi; Eytan Ruppin; Eyal Gottlieb
Journal:  Nature       Date:  2011-08-17       Impact factor: 49.962

8.  Purification and characterization of biliverdin reductase from rat liver.

Authors:  R K Kutty; M D Maines
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

Review 9.  Pharmacological and clinical aspects of heme oxygenase.

Authors:  Nader G Abraham; Attallah Kappas
Journal:  Pharmacol Rev       Date:  2008-03-06       Impact factor: 25.468

10.  Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells.

Authors:  Joana Carrelha; Yiran Meng; Laura M Kettyle; Tiago C Luis; Ruggiero Norfo; Verónica Alcolea; Hanane Boukarabila; Francesca Grasso; Adriana Gambardella; Amit Grover; Kari Högstrand; Allegra M Lord; Alejandra Sanjuan-Pla; Petter S Woll; Claus Nerlov; Sten Eirik W Jacobsen
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

View more
  2 in total

1.  Genetic pathways regulating hematopoietic lineage speciation: Factorial latent variable model analysis of single cell transcriptome.

Authors:  Zhaoyan Liu; Wei Zhu; Dmitri V Gnatenko; Natasha M Nesbitt; Wadie F Bahou
Journal:  Data Brief       Date:  2021-04-22

2.  Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway.

Authors:  Zhihui Gao; Xiaojian Ni; Bohao Zheng; Wentao Sun; Wenze Wan; Han Liu; Xiaoling Ni; Tao Suo; Na Li; Houbao Liu; Sheng Shen
Journal:  J Cancer       Date:  2022-04-04       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.